medicationPrescription only (US)Lovastatin is FDA-approved for hypercholesterolemia and cardiovascular risk reduction; its use in the cited Parkinson's disease trial was investigational and off-label
LovastatinBenefits, Dosage & Interactions
Also known as: Mevacor
Lovastatin (Mevacor, Altoprev) was the first statin approved in the United States. It inhibits HMG-CoA reductase, the rate-limiting enzyme in liver cholesterol synthesis, which lowers LDL cholesterol and cardiovascular risk. It is typically taken in the evening. Dose, response, and interaction risk vary by individual, so use should be reviewed with a clinician.
How much Lovastatin do people take?
The Parkinson's trial used lovastatin 40 mg once daily; the schizophrenia add-on trial studied simvastatin rather than lovastatin, so it is cited here only as adjacent statin-class evidence, not as direct lovastatin dosing. Route reported: Oral tablet. Frequency reported: Once daily, taken with the evening meal in the cited Parkinson's trial. These are amounts documented in the cited studies and labels for Lovastatin — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
See the full reported protocol and its sourcesResearched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
Evidence: Moderate — One published human randomized trial; results not yet replicated.
Evidence strengthModerate · 3/4
PreclinicalStrong human evidence
One published human randomized trial; results not yet replicated.
Quick answer
Lovastatin (Mevacor, Altoprev) was the first statin approved in the United States. It inhibits HMG-CoA reductase, the rate-limiting enzyme in liver cholesterol synthesis, which lowers LDL cholesterol and cardiovascular risk. Because that enzyme is most active overnight and lovastatin is short-acting, labeling directs the immediate-release form to be taken with the evening meal.
- Brand names
- Mevacor, Altoprev (extended-release)
- Drug class
- HMG-CoA reductase inhibitor (statin)
- Prescribed for
- High LDL cholesterol and cardiovascular risk reduction
- Timing
- Immediate-release with the evening meal; food improves absorption
- Potency
- Lower-intensity statin compared with atorvastatin or rosuvastatin
- Key interaction
- CYP3A4 — grapefruit, some antifungals, macrolides, HIV drugs
Compiled by DoseRoutine from public sources including NIH/MedlinePlus, the FDA label, Mayo Clinic and PubChem. Educational information, not medical advice.
Plasma half-life
Reported as short, on the order of a few hours, consistent with once-daily evening dosing
Typical timing
in the evening
Food rule
with food
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- The Parkinson's trial used lovastatin 40 mg once daily; the schizophrenia add-on trial studied simvastatin rather than lovastatin, so it is cited here only as adjacent statin-class evidence, not as direct lovastatin dosing[1]
- Route studied
- Oral tablet[1]
- Frequency
- Once daily, taken with the evening meal in the cited Parkinson's trial[1]
- Cycle length
- The Parkinson's trial followed patients for 2 years of continuous treatment[1]
- Half-life
- Reported as short, on the order of a few hours, consistent with once-daily evening dosing[1]
Reported for Lovastatin in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Lovastatin entry is written from. Each number matches an inline marker above.
- [1]A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson's DiseaseLin CH, Chang CH, Tai CH, Cheng MF, Chen YC, Chao YT, Huang TL, Yen RF, Wu RM · Movement Disorders · 2021 · Peer-reviewed · PMID 33449392
- [2]A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorderWeiser M, Levi L, Park J, Nastas I, Matei V, Davidson M, Arad I, Dudkiewicz I, Davis JM · European Neuropsychopharmacology · 2023 · Peer-reviewed · PMID 37126871
References & Evidence
Sources on this page that document Lovastatin dosing, timing and safety.
- [1]U.S. National Library of Medicine View source
- [2]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Lovastatin?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Lovastatin, marketed under brand names such as Mevacor, is a medication primarily used to reduce elevated cholesterol levels. It belongs to a class of drugs known as statins, or HMG-CoA reductase inhibitors. These medications work by interfering with the body's natural cholesterol production processes. Lovastatin is prescribed to help prevent cardiovascular events such as heart attacks and strokes in individuals at risk due to high cholesterol or other risk factors. It is available as an oral tablet and is typically taken once daily. The use of lovastatin, like other statins, is generally part of a broader treatment plan that includes dietary changes, exercise, and lifestyle modifications aimed at improving cardiovascular health (Mayo Clinic).
What does the research say about Lovastatin?
Tap a section to expand.
Lovastatin functions by inhibiting the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. This enzyme plays a crucial role in the liver's synthesis of cholesterol. By blocking HMG-CoA reductase, lovastatin reduces the production of cholesterol within the liver. This reduction in hepatic cholesterol leads to an increase in the number of low-density lipoprotein (LDL) receptors on the surface of liver cells. These increased receptors enhance the liver's ability to remove LDL cholesterol, often referred to as 'bad' cholesterol, from the bloodstream. Consequently, levels of total cholesterol, LDL cholesterol, and triglycerides decrease, while high-density lipoprotein (HDL) cholesterol, often referred to as 'good' cholesterol, may slightly increase. The overall effect is a reduction in circulating lipids, which contributes to the prevention of atherosclerosis (DrugBank, FDA label).
Source for this section: Sources for How does Lovastatin work?: Jumps to this entry in the sources and references list at the end of the page.
The primary benefits of lovastatin are related to its ability to manage lipid levels and thereby reduce the risk of cardiovascular disease. Key benefits include:
* **Reduction of LDL Cholesterol:** Lovastatin significantly lowers levels of low-density lipoprotein (LDL) cholesterol, which is a major risk factor for atherosclerosis and heart disease. Studies have consistently shown its efficacy in this regard (Cochrane).
* **Decrease in Total Cholesterol and Triglycerides:** It also helps to reduce total cholesterol and triglyceride levels in the blood, contributing to an overall healthier lipid profile (FDA label).
* **Increase in HDL Cholesterol:** While not its primary action, lovastatin can produce a modest increase in high-density lipoprotein (HDL) cholesterol, which is associated with a protective effect against cardiovascular disease (PubChem).
* **Prevention of Cardiovascular Events:** For individuals with existing coronary heart disease or those at high risk, lovastatin has been shown to reduce the incidence of major cardiovascular events, including heart attacks, strokes, and the need for revascularization procedures (MedlinePlus).
* **Slow Progression of Atherosclerosis:** By lowering cholesterol, lovastatin can help to slow down the progression of atherosclerosis, the hardening and narrowing of arteries caused by plaque buildup (Mayo Clinic).
Numerous large-scale clinical trials and meta-analyses support the efficacy of lovastatin and other statins in managing hyperlipidemia and preventing cardiovascular disease. Early landmark studies, such as the Scandinavian Simvastatin Survival Study (4S), which included a precursor to lovastatin, demonstrated significant reductions in mortality and major coronary events. Subsequent research has replicated these findings across various populations.
A systematic review published by Cochrane evaluated the effects of statins, including lovastatin, on cardiovascular outcomes and found strong evidence for their role in reducing the risk of myocardial infarction, stroke, and cardiovascular mortality in patients with and without pre-existing cardiovascular disease. The review highlighted that the benefits are generally consistent across different statins, with lovastatin demonstrating comparable effects in lowering LDL-C and improving outcomes.
The FDA label for lovastatin includes data from clinical trials demonstrating its effectiveness in reducing total and LDL cholesterol in patients with hypercholesterolemia. For example, trials have shown dose-dependent reductions in LDL-C ranging from 20% to over 40%. The long-term benefits in reducing cardiovascular morbidity and mortality are well-documented in observational studies and clinical trials following initial approval (FDA label, Cochrane).
Like all medications, lovastatin can cause side effects, though not everyone experiences them. Common side effects are generally mild and may include:
* Headache
* Muscle pain, tenderness, or weakness (myalgia)
* Digestive issues such as constipation, diarrhea, nausea, or abdominal pain
* Fatigue
* Insomnia
More serious, but less common, side effects can occur and require immediate medical attention:
* **Myopathy and Rhabdomyolysis:** This is a rare but serious condition involving severe muscle pain, weakness, and dark urine, which can lead to kidney damage. The risk is higher with higher doses, in older individuals, or when taken with certain other medications (DrugBank).
* **Liver Problems:** Lovastatin can occasionally cause an increase in liver enzymes, indicating liver inflammation. Regular monitoring of liver function during treatment is sometimes recommended (MedlinePlus).
* **Memory Loss or Confusion:** Some individuals have reported cognitive issues, though the link to statin use is not fully established and often resolves upon discontinuation (Mayo Clinic).
* **Increased Blood Sugar and Diabetes Risk:** Statins may cause a small increase in blood sugar and, in some cases, contribute to the development of type 2 diabetes, particularly in those with pre-existing risk factors (NIH NIDDK).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for What are the side effects of Lovastatin?: Jumps to this entry in the sources and references list at the end of the page.
Several important warnings are associated with lovastatin use:
* **Muscle Problems:** Patients should be advised to report any unexplained muscle pain, tenderness, or weakness, especially if accompanied by fever or malaise. This could be a sign of a serious muscle condition (myopathy or rhabdomyolysis). The risk is increased with co-administration of certain drugs and in patients with particular genetic predispositions or medical conditions (FDA label).
* **Liver Function:** Liver enzyme levels should be checked before starting therapy and periodically thereafter. If persistent elevations in liver enzymes occur, the medication may need to be discontinued (MedlinePlus).
* **Kidney Impairment:** Patients with severe kidney impairment may require careful dosing adjustments as lovastatin is primarily eliminated through the kidneys (DrugBank).
* **Risk of Diabetes Mellitus:** Statins have been observed to increase HbA1c and fasting serum glucose levels. Close monitoring of blood glucose is recommended, especially in patients at high risk for developing diabetes (Mayo Clinic).
* **Grapefruit Juice Consumption:** Concurrent consumption of large amounts of grapefruit juice should be avoided as it can increase the concentration of lovastatin in the body, raising the risk of side effects (Examine.com).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for Who should avoid Lovastatin?: Jumps to this entry in the sources and references list at the end of the page.
Lovastatin is contraindicated in several circumstances to prevent adverse effects:
* **Active Liver Disease:** This includes unexplained persistent elevations of serum transaminases. Lovastatin should not be used in patients with active liver disease due to the potential for further liver damage (FDA label).
* **Pregnancy and Lactation:** Lovastatin is contraindicated in pregnant women because it can cause fetal harm. Cholesterol and its byproducts are essential for fetal development. Similarly, it is contraindicated in nursing mothers as statins are excreted in human milk, and there is a potential for serious adverse reactions in the infant (MedlinePlus).
* **Hypersensitivity:** Individuals with a known hypersensitivity to lovastatin or any component of the formulation should not use this medication (DrugBank).
* **Concomitant use of strong CYP3A4 inhibitors:** As detailed in 'Do Not Mix,' certain medications that are strong inhibitors of the CYP3A4 enzyme should not be taken with lovastatin due to significantly increased risk of myopathy and rhabdomyolysis (FDA label).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for When should Lovastatin not be taken?: Jumps to this entry in the sources and references list at the end of the page.
Certain medications and substances should not be combined with lovastatin due to an increased risk of severe adverse effects, particularly muscle problems (myopathy/rhabdomyolysis) or liver toxicity:
* **Strong CYP3A4 Inhibitors:** These include certain antifungal medications (e.g., itraconazole, ketoconazole, posaconazole, voriconazole), macrolide antibiotics (e.g., erythromycin, clarithromycin, telithromycin), HIV protease inhibitors (e.g., nelfinavir, ritonavir), and the antidepressant nefazodone. These drugs can significantly increase lovastatin levels in the blood (FDA label).
* **Gemfibrozil, Cyclosporine, Cobicistat, Danazol:** These medications increase the risk of muscle damage when taken with lovastatin (DrugBank).
* **Large Quantities of Grapefruit Juice:** More than a quart per day can inhibit the metabolism of lovastatin and increase its concentration, thereby raising the risk of side effects like rhabdomyolysis (Examine.com).
* **Colchicine:** Coadministration with lovastatin has been associated with reports of myopathy and rhabdomyolysis (MedlinePlus).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for What should you not mix with Lovastatin?: Jumps to this entry in the sources and references list at the end of the page.
Lovastatin is typically taken once daily in the evening, sometimes specifically at bedtime. This timing is recommended because cholesterol synthesis by the liver tends to increase during the night. Taking the medication with the evening meal or dinner is generally advised. This helps maximize its absorption and effectiveness. Individual needs vary, and the precise timing and dose must be set by a licensed clinician (FDA label).
Source for this section: Sources for When should you take Lovastatin?: Jumps to this entry in the sources and references list at the end of the page.
Put it into practice
Reading about Lovastatin is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.
What interacts with Lovastatin?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Any vitamin + medication | Note | Category ruleConfidence: theoretical | Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Specific pairs are checked against a licensed source; confirm with your provider. |
| Berberine | Caution | Compound pairConfidence: theoretical | Berberine inhibits CYP3A4 and P-glycoprotein, raising statin levels and myopathy risk.Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Separate dosing and monitor for muscle pain; consider lower statin dose. |
| Any + | Caution | Category ruleConfidence: theoretical | Berberine inhibits CYP3A4 and P-glycoprotein, raising statin levels and myopathy risk.Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Separate dosing and monitor for muscle pain. |
| CoQ10 (Ubiquinol) | Complementary | Compound pairConfidence: theoretical | Statins block CoQ10 biosynthesis via the mevalonate pathway; supplementing may reduce muscle symptoms.Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Consider 100–200 mg CoQ10 daily while on a statin. |
Frequently asked questions about Lovastatin
Lovastatin, like other statins (e.g., simvastatin, atorvastatin), works by inhibiting the HMG-CoA reductase enzyme to lower cholesterol. While they share a common mechanism, they differ in potency, half-life, and interactions with other drugs. A clinician determines the most appropriate statin based on individual patient needs and other medications.
Cholesterol levels typically begin to decrease within a few weeks of starting lovastatin, but the full effect on lipid levels is usually seen within 4 to 6 weeks of consistent use. For cardiovascular event prevention, the benefits are long-term and require continuous treatment (MedlinePlus).
Lovastatin is often prescribed for long-term management of high cholesterol and to reduce cardiovascular risk. Stopping the medication, even if cholesterol levels have normalized, can lead to a return of high cholesterol. Any decision to stop or change medication should only be made in consultation with a licensed clinician (Mayo Clinic).
Muscle pain, tenderness, or weakness (myalgia) is a recognized side effect of lovastatin and other statins. While often mild, severe muscle problems like myopathy or rhabdomyolysis are rare but serious. It is important to report any new or worsening muscle symptoms to a healthcare provider promptly (FDA label).
Interaction risk for Lovastatin comes from the rest of the stack: other medications, prescription medicines, hormone therapy and peptides. Because Lovastatin is usually taken in the evening, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Lovastatin with no sign-up.
Lovastatin is typically taken in the evening. Published protocols usually have it taken with food. Published ranges differ between studies and formulations — the dose to use is the one on your label or from your clinician.
There is no single answer for Lovastatin plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing Lovastatin with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Lovastatin varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the evening. Most protocols have it taken with food. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Lovastatin depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Lovastatin the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
The liver makes most of its cholesterol overnight, and lovastatin has a short half-life, so evening dosing lines the drug up with peak enzyme activity. Higher-potency, longer-acting statins such as atorvastatin and rosuvastatin do not require this. This is educational information, not medical advice.
Grapefruit inhibits intestinal CYP3A4, the enzyme that clears lovastatin, and can raise blood levels several-fold — increasing the risk of muscle injury and rhabdomyolysis. Lovastatin and simvastatin are the statins most affected; pravastatin and rosuvastatin are largely unaffected. This is educational information, not medical advice.
Atorvastatin is a higher-intensity, longer-acting statin that lowers LDL more per dose, can be taken at any time of day, and is less sensitive to grapefruit. Lovastatin remains in use as an older, lower-cost, moderate-intensity option. This is educational information, not medical advice.
The Parkinson's trial used lovastatin 40 mg once daily; the schizophrenia add-on trial studied simvastatin rather than lovastatin, so it is cited here only as adjacent statin-class evidence, not as direct lovastatin dosing. Route reported: Oral tablet. Frequency reported: Once daily, taken with the evening meal in the cited Parkinson's trial. These are amounts documented in the cited studies and labels for Lovastatin — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- MedlinePlus(opens in a new tab)U.S. National Library of Medicine · medlineplus.gov/druginfo/meds/a688006.html
- PubChem CID 53232(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/53232
Verify at
Publisher search links for Lovastatin. These are places to check the information — they are not citations, so they are not numbered.
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Lovastatin?
Plain-text summary, safe to quote verbatim:
Lovastatin (Mevacor, Altoprev) was the first statin approved in the United States. It inhibits HMG-CoA reductase, the rate-limiting enzyme in liver cholesterol synthesis, which lowers LDL cholesterol and cardiovascular risk. It is typically taken in the evening. Dose, response, and interaction risk vary by individual, so use should be reviewed with a clinician.
Source: DoseRoutine — https://doseroutine.com/library/lovastatin
Lovastatin cheat sheet
DoseRoutine cheat sheet · Medication
Lovastatin
Lovastatin (Mevacor, Altoprev) was the first statin approved in the United States. It inhibits HMG-CoA reductase, the rate-limiting enzyme in liver cholesterol synthesis, which lowers LDL cholesterol and cardiovascular risk.
Evidence
Moderate
One published human randomized trial; results not yet replicated.
Studied range
The Parkinson's trial used lovastatin 40 mg once daily; the schizophrenia add-on trial studied simvastatin rather than lovastatin, so it is cited here only as adjacent statin-class evidence, not as direct lovastatin dosing
Route
Oral tablet
Frequency studied
Once daily, taken with the evening meal in the cited Parkinson's trial
Half-life
Reported as short, on the order of a few hours, consistent with once-daily evening dosing
Timing
in the evening
With food
with food
Prescription only (US)Lovastatin is FDA-approved for hypercholesterolemia and cardiovascular risk reduction; its use in the cited Parkinson's disease trial was investigational and off-label
Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/lovastatin
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Lovastatin — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/lovastatin
What compounds are similar to Lovastatin?
Others in the medication category or studied for the same goals.